Minimal Residual Disease Testing
Current Innovations and Future Directions
(Sprache: Englisch)
This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
82.49 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Minimal Residual Disease Testing “
Klappentext zu „Minimal Residual Disease Testing “
This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD. Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.
Inhaltsverzeichnis zu „Minimal Residual Disease Testing “
1. IntroductionNitin Mahajan, Todd Druley2. Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia/LymphomaLaura Wake, Xueyan Chen, Michael J. Borowitz
3. Molecular Diagnostics for Minimal Residual Disease Analysis in Hematopoietic MalignanciesBarbara K. Zehentner
4. Monitoring AML Response Using "Difference From Normal" Flow CytometryMichael R. Loken, Lisa Eidenschink Brodersen, Denise A. Wells
5. ML-DS: A Unique Condition for Measurable Residual Disease Detection Elisabeth R. Wilson, R. Spencer Tong
6. Advancements in Next Generation Sequencing for Detecting Minimal Residual DiseaseErin L. Crowgey, Nitin Mahajan
Autoren-Porträt
Todd E. Druley, MD, PhDAssociate Professor of Pediatrics, Genetics and Developmental BiologyDirector, Fellowship Program in Pediatric Hematology and OncologyDirector, Pediatric Cancer Predisposition ProgramWashington University in St. LouisDepartment of PediatricsDivision of Hematology and OncologyCenter for Genome Sciences and Systems BiologySt. Louis, MO USA
Bibliographische Angaben
- 2018, 1st ed. 2019, VIII, 197 Seiten, 27 farbige Abbildungen, Maße: 12,7 x 20,3 cm, Kartoniert (TB), Englisch
- Herausgegeben: Todd E. Druley
- Verlag: Springer, Berlin
- ISBN-10: 3319948261
- ISBN-13: 9783319948263
- Erscheinungsdatum: 27.11.2018
Sprache:
Englisch
Kommentar zu "Minimal Residual Disease Testing"
Schreiben Sie einen Kommentar zu "Minimal Residual Disease Testing".
Kommentar verfassen